Wide-ranging stakeholders are continuing to press Congress to again delay or to repeal the Affordable Care Act’s fees on health insurance and medical devices, and are strongly pushing lawmakers to fully repeal the forthcoming 40% excise tax on high-cost plans, or the “Cadillac tax,” prior to the end of the year. Some stakeholders argue that hurdles facing legislation to curb surprise billing and to lower drug prices put lawmakers at risk of returning home in December with little to show,...